MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202421004713 A) filed by Healthledger Private Limited, Pune, Maharashtra, on Jan. 23, 2024, for 'assay, primers, and probes for detection of mycobacterium tuberculosis.'
Inventor(s) include Chandak, Darshankumar; and Banerjee, Gautam.
The application for the patent was published on July 25, under issue no. 30/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure provides a cost-effective, highly sensitive, and specific method for the detection of Mycobacterium tuberculosis and its rifampicin-resistant strain. In particular, the present disclosure provides primer sets and probes. Further, the present disclosure provides a kit comprising the primer sets and the probes for detecting Mycobacterium tuberculosis and rifampicin-resistant M. tuberculosis in a biological sample. Furthermore, the present disclosure provides an assay for detecting Mycobacterium tuberculosis and rifampicin-resistant M. tuberculosis in the biological sample employing the primer sets and the probes."
Disclaimer: Curated by HT Syndication.
